Open AccessIs low threshold of B cells an obligatory monitoring indicator of repeated RTX infusion in the treatment of Neuromyelitis Optica spectrum disorder? – A report of two cases
Author(s) -
Lijun Jing,
Hai Yu,
Jiatong Li,
Yarong Li,
Xiaoni Liu,
Haifeng Li,
Xiangjun Chen
Publication year - 2021
Publication title -
neuroimmunology reports
Language(s) - English
Resource type - Journals
ISSN - 2667-257X
DOI - 10.1016/j.nerep.2021.100023
Subject(s) - neuromyelitis optica , cd19 , rituximab , medicine , spectrum disorder , adverse effect , immunology , antibody , psychiatry